News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Election 2014, Local

Durbin and Oberweis Debate Again

Fresh
vote

'entrenched insider' versus 'perennial candidate'

in Local

IDOT: Follow the Rules of the Road This Weekend

Fresh
local_news_generic

Click It or Ticket! Drive Sober or Get Pulled Over!

in Local

Rauner Unimpressed with Recent Economic Announcements

Bruce Rauner (R), Pat Quinn

Rauner says recent economic developments won’t do much for Quinn’s overall economic record.

in Local

Milhiser: Andrea Little Could Face More Charges in DUI Deaths

ANDREA LITTLE 102052

Next court appearance set for November

in Local

Parsons Fails to Appear in Federal Bankruptcy Trial

Jeff Parsons appears defiant as he walks out of federal court in Springfield July 10, 2014

The federal bankruptcy trial of Jeff Parsons continued Wednesday even though Parsons didn't show up.